Latest News

Kalbe Launched Insulin Pumo

The Latest Therapy for Diabetics

Kalbe Launched Insulin Pumo

Jakarta, 27th March 2012 – Kalbe Group (Kalbe) today launched a variant of health equipment for diabetic patients, an insulin pump, which will be distributed under PT Enseval Medika Prima (EMP), one of Kalbe Group’s subsidiary operating in the healthcare equipment line.

“We see the number of diabetic patients grow year after year, and therefore try to help them to avoid the long term complication of the diabetic disease,” said Irawati Setiady, President Director for Kalbe Group. “With the latest therapy method to deal with diabetic offered by this insulin pump, Kalbe hopes to answer the challenges in providing better living for Indonesian people.”According to the World Health Organization (WHO), there are approximately 346 millions diabetic patients to date, with 80% death rate caused by diabetic coming from middle and low income countries. Many people consider diabetic as a common disease, while in fact, diabetic is a disease with the most complications. Through research and development, Kalbe has always tried to provide the best medication as well as methods in overcoming many diseases in Indonesia, including diabetic.

The insulin pump which will be distributed under EMP is a product of Sooil Co., Ltd Korea, a company with 30 years of dedication to the betterment of diabetic patients quality of living. This healthcare equipment named Dana Diabecare Insulin Pump is the latest therapy for diabetic patients to avoid complications and to stabilize the blood sugar level.

About PT Enseval Medika Prima
PT Enseval Medika Prima (EMP) was established in 2007 and is a division of PT Enseval Putra Megatrading Tbk (EMPT) which is one of Kalbe’s sub-business unit. EMP is a healthcare equipment marketing company which has four business units; hospital specialty (HosPec), hospital laboratort (HosLab), hospital support (HosPort) and Patient Care Management (PCM). A few products disributed under the company is Biomerius, Thermo Scientific, General Electric, Becton Dickinson, Covidien, Boston Scientific and many more. EMP has branches across 32 cities all over Indonesia.

About Kalbe
PT Kalbe Farma Tbk (“Kalbe”) was founded in 1966. It is one of the largest public listed pharmaceutical company in South East Asia. Kalbe has four main divisions which handle leading brands and vast portfolio - prescribed medicines business unit (Cefspan, Brainact, Broadced, etc); over the counter products (Woods, Promag, Mixagrip, Komix, Fatigon, etc); nutritionals (ChilKid, Prenagen, Diabetasol, etc); and distribution. Kalbe has more than twenty subsidiaries, nine production facilities with international standard, and hire more than 15,000 employees as well as 4,000 marketing and sales forces distributed across 65 branches all over Indonesia. Since 1991, Kalbe has been enlisted in the Jakarta Stock Exchange (IDX:KLBF).

5118 Rate this article:

Please login or register to post comments.